Comparison Chart Compass Therapeutics, Inc.
Stocks
CMPX
US20454B1044
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.270 USD | +4.13% |
|
+9.66% | -57.73% |
| 06-29 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000E Growth Benchmark | CI |
| 06-28 | Compass Therapeutics, Inc.(NasdaqCM:CMPX) dropped from Russell 3000 Growth Benchmark | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMPASS THERAPEUTICS, INC. | Bio Therapeutic Drugs | +4.13% | +9.66% | -57.73% | -13.36% | -53.67% | 409M |  |  | |
- Stock Market
- Stocks
- CMPX Stock
- Charts Compass Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
